DalsnaFinance › Analyst accuracy › Barclays › AMGN target
AMGN Maintained by Barclays -- Price Target Raised to $360
Barclays upped their price objective on shares of Amgen from $350.00 to $360.00 and gave the stock an 'equal weight' rating in a research report issued on Wednesday
A fact about what Barclays published, as reported by GuruFocus, not a recommendation from Dalsna Finance; Barclays is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.